Low molecular weight heparin versus unfractionated heparin for thromboprophylaxis in patients with acute atrial fibrillation: A randomized control trial

Chung-Wah SiuCardiology Division, Department of Medicine, Queen Mary Hospital, the University of Hong Kong, Hong KongCorrespondence[email protected]

Man-Hong JimCardiology Division, Department of Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong

Chu-Pak LauCardiology Division, Department of Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong

Hung-Fat TseCardiology Division, Department of Medicine, Queen Mary Hospital, the University of Hong Kong, Hong KongCorrespondence[email protected]
[email protected]

References

Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham heart study. Circulation 1998;98:946–52.
PubMed Web of Science ®Google Scholar
Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke; a journal of cerebral circulation 1986;17:622–6.
PubMed Web of Science ®Google Scholar
Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: The Framinghamstudy. Stroke; a journal of cerebral circulation 1983;14:664–7.
PubMed Web of Science ®Google Scholar
Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transeso phageal echocardiographic study. J Am Coll Cardiol. 1995;25: 452–9.
PubMed Web of Science ®Google Scholar
Stoddard MF. Risk of thromboembolism in acute atrial fibrillation or atrial flutter. Echocardiography 2000;17:393–4.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Low molecular weight heparin versus unfractionated heparin for thromboprophylaxis in patients with acute atrial fibrillation: A randomized control trial

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Low molecular weight heparin versus unfractionated heparin for thromboprophylaxis in patients with acute atrial fibrillation: A randomized control trial

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date